Published in J Clin Epidemiol on November 01, 1998
What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual Life Outcomes (2003) 3.42
Improving the use of research evidence in guideline development: 10. Integrating values and consumer involvement. Health Res Policy Syst (2006) 2.93
Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans. Ann Intern Med (2011) 2.35
Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study. Ann Intern Med (2014) 1.87
Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax (2001) 1.67
Reconsidering the use of rankings in the valuation of health states: a model for estimating cardinal values from ordinal data. Popul Health Metr (2003) 1.63
Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt. J Hepatol (2007) 1.59
Use of patient-reported outcomes in the context of different levels of data. J Bone Joint Surg Am (2011) 1.56
Mapping SF-36 onto the EQ-5D index: how reliable is the relationship? Health Qual Life Outcomes (2009) 1.55
The impact of diabetes mellitus and other chronic medical conditions on health-related Quality of Life: is the whole greater than the sum of its parts? Health Qual Life Outcomes (2005) 1.52
A comparison of health utility measures for the evaluation of multiple sclerosis treatments. J Neurol Neurosurg Psychiatry (2005) 1.50
Cost-utility estimation of surgical treatment of pancreatic carcinoma aimed at cure. World J Surg (2011) 1.47
Correlates of quality of life in overweight or obese breast cancer survivors at enrollment into a weight loss trial. Psychooncology (2015) 1.40
Health-related quality of life among adults who experienced maltreatment during childhood. Am J Public Health (2008) 1.36
Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs. Arthritis Res Ther (2014) 1.35
Outcome measurement in economic evaluations of public health interventions: a role for the capability approach? Int J Environ Res Public Health (2010) 1.35
Cost-effectiveness of enhancing primary care depression management on an ongoing basis. Ann Fam Med (2005) 1.30
Quality of life instruments and definitions in individuals with spinal cord injury: a systematic review. Spinal Cord (2009) 1.27
Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study. Heart (2006) 1.26
Changes in health state utilities with changes in body mass in the Diabetes Prevention Program. Obesity (Silver Spring) (2009) 1.24
Reducing breast cancer recurrence with weight loss, a vanguard trial: the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial. Contemp Clin Trials (2012) 1.22
Importance of sociodemographic and morbidity aspects in measuring health-related quality of life: performances of three tools: comparison of three questionnaire scores. Eur J Health Econ (2008) 1.12
Randomized, controlled trial of an intervention to enable stroke survivors throughout the Los Angeles County safety net to "stay with the guidelines". Circ Cardiovasc Qual Outcomes (2011) 1.11
Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease. Health Qual Life Outcomes (2006) 1.10
Vision and quality of life: development of methods for the VisQoL vision-related utility instrument. Ophthalmic Epidemiol (2008) 1.08
Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis? Health Qual Life Outcomes (2013) 1.05
How bad is depression? Preference score estimates from depressed patients and the general population. Health Serv Res (2009) 1.01
The North American Opiate Medication Initiative (NAOMI): profile of participants in North America's first trial of heroin-assisted treatment. J Urban Health (2008) 0.99
Cost-effectiveness of a primary care depression intervention. J Gen Intern Med (2003) 0.99
The ability of cancer-specific and generic preference-based instruments to discriminate across clinical and self-reported measures of cancer severities. Health Qual Life Outcomes (2011) 0.98
Health related quality of life outcome instruments. Eur Spine J (2005) 0.98
Comparison of EQ-5D, HUI, and SF-36-derived societal health state values among spine patient outcomes research trial (SPORT) participants. Qual Life Res (2005) 0.98
Mapping CushingQoL scores onto SF-6D utility values in patients with Cushing's syndrome. Patient (2013) 0.97
Disease-modifying drugs for knee osteoarthritis: can they be cost-effective? Osteoarthritis Cartilage (2013) 0.96
Health-related quality of life and hearing aids: a tutorial. Trends Amplif (2005) 0.95
Can we derive an 'exchange rate' between descriptive and preference-based outcome measures for stroke? Results from the transfer to utility (TTU) technique. Health Qual Life Outcomes (2009) 0.95
Measuring preferences for cost-utility analysis: how choice of method may influence decision-making. Pharmacoeconomics (2007) 0.94
Five-year stability in associations of health-related quality of life measures in community-dwelling older adults: the Rancho Bernardo Study. Qual Life Res (2010) 0.92
The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach. HIV Med (2007) 0.92
Predicting SF-6D utility scores from the Oswestry disability index and numeric rating scales for back and leg pain. Spine (Phila Pa 1976) (2009) 0.92
Quality of life: what does it mean for general practice? Br J Gen Pract (2009) 0.91
Complications among colorectal cancer survivors: SF-6D preference-weighted quality of life scores. Med Care (2011) 0.90
Health-related quality of life changes associated with buprenorphine treatment for opioid dependence. Qual Life Res (2011) 0.89
A longitudinal comparison of 5 preference-weighted health state classification systems in persons with intervertebral disk herniation. Med Decis Making (2010) 0.89
Cost utility analysis of reverse total shoulder arthroplasty. J Shoulder Elbow Surg (2013) 0.89
Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual Life Res (2015) 0.89
How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis? Ann Rheum Dis (2007) 0.88
Moving MobileMums forward: protocol for a larger randomized controlled trial of an improved physical activity program for women with young children. BMC Public Health (2013) 0.88
Quality-adjusted life-years gain and health status in patients with OSAS after one year of continuous positive airway pressure use. Sleep (2014) 0.88
Economic evaluations of homeopathy: a review. Eur J Health Econ (2013) 0.87
Cost-effectiveness of a nurse-led telemonitoring intervention based on peak expiratory flow measurements in asthmatics: results of a randomised controlled trial. Cost Eff Resour Alloc (2007) 0.87
Pharmacologic regimens for knee osteoarthritis prevention: can they be cost-effective? Osteoarthritis Cartilage (2014) 0.86
Cervical spondylotic myelopathy surgical trial: randomized, controlled trial design and rationale. Neurosurgery (2014) 0.86
Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D. Health Qual Life Outcomes (2013) 0.86
SF-6D and EQ-5D result in widely divergent incremental cost-effectiveness ratios in a clinical trial of older women: implications for health policy decisions. Osteoporos Int (2011) 0.85
Longitudinal association of preference-weighted health-related quality of life measures and substance use disorder outcomes. Addiction (2011) 0.85
Stakeholders in outcome measures: review from a clinical perspective. Clin Orthop Relat Res (2013) 0.84
Measuring Health Utilities in Children and Adolescents: A Systematic Review of the Literature. PLoS One (2015) 0.84
Assessing the empirical validity of alternative multi-attribute utility measures in the maternity context. Health Qual Life Outcomes (2009) 0.83
Mapping CushingQOL scores to EQ-5D utility values using data from the European Registry on Cushing's syndrome (ERCUSYN). Qual Life Res (2013) 0.83
Preference-weighted health-related quality of life measures and substance use disorder severity. Addiction (2008) 0.82
Predicting SF-6D utility scores from the neck disability index and numeric rating scales for neck and arm pain. Spine (Phila Pa 1976) (2011) 0.82
Towards a better understanding of the role of psychological variables in arthritis outcome research. Arthritis Res Ther (2010) 0.81
Use of the Tailored Activities Program to reduce neuropsychiatric behaviors in dementia: an Australian protocol for a randomized trial to evaluate its effectiveness. Int Psychogeriatr (2014) 0.80
SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus. Ann Rheum Dis (2011) 0.80
Cost-utility estimations of palliative care in patients with pancreatic adenocarcinoma: a retrospective analysis. World J Surg (2013) 0.80
Health economics research into supporting carers of people with dementia: a systematic review of outcome measures. Health Qual Life Outcomes (2012) 0.80
Predicting EQ-5D-US and SF-6D societal health state values from the Osteoporosis Assessment Questionnaire. Osteoporos Int (2011) 0.80
Asthma control cost-utility randomized trial evaluation (ACCURATE): the goals of asthma treatment. BMC Pulm Med (2011) 0.79
Evidence from cost-effectiveness research. NeuroRx (2004) 0.79
Estimating quality-adjusted life years from patient-reported visual functioning. Eye (Lond) (2012) 0.79
Unchained melody: revisiting the estimation of SF-6D values. Eur J Health Econ (2015) 0.79
Development of the Incontinence Utility Index: estimating population-based utilities associated with urinary problems from the Incontinence Quality of Life Questionnaire and Neurogenic Module. Health Qual Life Outcomes (2014) 0.79
Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxis. Expert Rev Pharmacoecon Outcomes Res (2015) 0.79
Cost-effectiveness of a nurse-led education and psychosocial programme for patients with chronic heart failure and their partners. J Clin Nurs (2013) 0.78
Economic Evaluation of Recombinant Human Thyroid Stimulating Hormone Stimulation vs. Thyroid Hormone Withdrawal Prior to Radioiodine Ablation for Thyroid Cancer: The Korean Perspective. Endocrinol Metab (Seoul) (2015) 0.78
SLIMMER: a randomised controlled trial of diabetes prevention in Dutch primary health care: design and methods for process, effect, and economic evaluation. BMC Public Health (2014) 0.78
Estimation of utility values from visual analog scale measures of health in patients undergoing cardiac surgery. Clinicoecon Outcomes Res (2014) 0.78
Efficacy and cost-effectiveness of a web-based intervention with mobile phone support to treat depressive symptoms in adults with diabetes mellitus type 1 and type 2: design of a randomised controlled trial. BMC Psychiatry (2013) 0.78
Physical violence and health-related quality of life: Danish cross-sectional analyses. Health Qual Life Outcomes (2012) 0.78
Quality of life outcomes from the Exercise and Nutrition Enhance Recovery and Good Health for You (ENERGY)-randomized weight loss trial among breast cancer survivors. Breast Cancer Res Treat (2015) 0.78
SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE Open Med (2016) 0.78
A three-group study, internet-based, face-to-face based and standard- management after acute whiplash associated disorders (WAD) - choosing the most efficient and cost-effective treatment: study protocol of a randomized controlled trial. BMC Musculoskelet Disord (2009) 0.77
Measurement and comparison of health utility assessments in chronic rhinosinusitis. Int Forum Allergy Rhinol (2015) 0.77
The impact of different health dimensions on overall quality of life related to kyphoplasty and non-surgical management. Osteoporos Int (2013) 0.77
Reported Outcome Measures in Degenerative Cervical Myelopathy: A Systematic Review. PLoS One (2016) 0.77
Targeted screening for Coeliac Disease among irritable bowel syndrome patients: analysis of cost-effectiveness and value of information. Eur J Health Econ (2012) 0.77
Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial. BMC Pulm Med (2017) 0.77
Assessing Health-Related Quality of Life of Chinese Adults in Heilongjiang Using EQ-5D-3L. Int J Environ Res Public Health (2017) 0.76
Deriving a preference-based utility measure for cancer patients from the European Organisation for the Research and Treatment of Cancer's Quality of Life Questionnaire C30: a confirmatory versus exploratory approach. Patient Relat Outcome Meas (2014) 0.76
How do medical students value health on the EQ-5D? Evaluation of hypothetical health states compared to the general population. Health Qual Life Outcomes (2008) 0.75
Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer. Iran Red Crescent Med J (2016) 0.75
Comparison of the Multiattribute Utility Instruments EQ-5D and SF-6D in a Europe-Wide Population-Based Cohort of Patients with Inflammatory Bowel Disease 10 Years after Diagnosis. Gastroenterol Res Pract (2016) 0.75
Within-trial economic evaluation of diabetes-specific cognitive behaviour therapy in patients with type 2 diabetes and subthreshold depression. BMC Public Health (2010) 0.75
Design of a randomized controlled trial of Internet-based cognitive behavioral therapy for treatment-induced menopausal symptoms in breast cancer survivors. BMC Cancer (2016) 0.75
CBT4BN: A Randomized Controlled Trial of Online Chat and Face-to-Face Group Therapy for Bulimia Nervosa. Psychother Psychosom (2016) 0.75
Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ (1992) 26.37
Workload of general practitioners before and after the new contract. BMJ (1992) 6.31
The C. elegans genome sequencing project: a beginning. Nature (1992) 5.36
Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol (2000) 4.58
Estimates of general practitioner workload: a review. J R Coll Gen Pract (1989) 4.04
Minor surgery by general practitioners under the 1990 contract: effects on hospital workload. BMJ (1993) 3.88
Community refinement of glaucoma referrals. Eye (Lond) (2003) 3.47
Evaluating the new Medigap standardization regulations. Health Aff (Millwood) (1992) 3.28
The York acupuncture safety study: prospective survey of 34 000 treatments by traditional acupuncturists. BMJ (2001) 3.05
Human testis-specific PGK gene lacks introns and possesses characteristics of a processed gene. Nature (1987) 3.04
Nonreciprocal exchanges of information between DNA duplexes coinjected into mammalian cell nuclei. Mol Cell Biol (1985) 3.00
Quality of minor surgery by general practitioners in 1990 and 1991. Br J Gen Pract (1994) 3.00
Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin Infect Dis (1999) 2.74
Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2009) 2.73
A review of the use of health status measures in economic evaluation. Health Technol Assess (1999) 2.62
X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet (1975) 2.57
Generic and condition-specific outcome measures for people with osteoarthritis of the knee. Rheumatology (Oxford) (1999) 2.51
The relationship between chromosome structure and function at a human telomeric region. Nat Genet (1997) 2.48
Evaluation of two treatment regimens of pralidoxime (1 gm single bolus dose vs 12 gm infusion) in the management of organophosphorus poisoning. J Assoc Physicians India (1996) 2.46
Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease. Sex Transm Infect (2003) 2.40
A high rate of caesarean sections in an affluent section of Chennai: is it cause for concern? Natl Med J India (1999) 2.32
Do general practitioners' attitudes towards depression predict their clinical behaviour? Psychol Med (2000) 2.25
Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec (2001) 2.18
Immune deficiency syndrome in children. JAMA (1983) 2.12
Couch or crouch? Examining the prostate: a randomized study comparing the knee-elbow and the left-lateral position. BJU Int (2001) 2.01
Brain-derived acidic fibroblast growth factor: complete amino acid sequence and homologies. Science (1985) 1.99
Baby Friendly Hospital Initiative: the Kerala experience. Indian Pediatr (1997) 1.98
Can we prevent accidental injury to adolescents? A systematic review of the evidence. Inj Prev (1995) 1.96
Pooled Estimates of Parent-Child Correlations in Stature from Birth to Maturity. Science (1962) 1.96
PCR-Enzyme immunoassay for detection of Streptococcus pneumoniae DNA in cerebrospinal fluid samples from patients with culture-negative meningitis. J Clin Microbiol (1998) 1.87
Changes in expression of albumin and alpha-fetoprotein genes during rat liver development and neoplasia. Biochemistry (1979) 1.86
Personal telephone electrocardiogram transmitter. Lancet (1973) 1.86
Predicting and evaluating response to omalizumab in patients with severe allergic asthma. Respir Med (2007) 1.86
Scrub typhus among hospitalised patients with febrile illness in South India: magnitude and clinical predictors. J Infect (2006) 1.71
A prospective survey of adverse events and treatment reactions following 34,000 consultations with professional acupuncturists. Acupunct Med (2001) 1.70
Cerebral fungal infections in the immunocompromised host: a literature review and a new pathogen--Chaetomium atrobrunneum: case report. Neurosurgery (1998) 1.69
Genital syndromes and syndromic management of vaginal discharge in a community setting. Int J STD AIDS (2004) 1.64
Treatment of diabetic ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the endpoint of emergency management. A randomized controlled study. Diabetes Care (1997) 1.64
EVerT: cryotherapy versus salicylic acid for the treatment of verrucae--a randomised controlled trial. Health Technol Assess (2011) 1.62
An evaluation of the implementation of a programme to improve end-of-life care in nursing homes. Palliat Med (2009) 1.60
Clinical effectiveness of pneumococcal vaccine. Meta-analysis. Can Fam Physician (1999) 1.60
Activity of mecillinam against ESBL producers in vitro. J Antimicrob Chemother (2005) 1.60
Runaway pacemaker rhythm after 36 hours of electrical inactivity. Br Heart J (1974) 1.60
Transient basophilia following the application of lymphatic pump techniques: a pilot study. J Am Osteopath Assoc (1998) 1.57
Inactivation of coxsackieviruses B3 and B5 in water by chlorine. Appl Environ Microbiol (1980) 1.53
Chloroplast DNA variation in pearl millet and related species. Genetics (1984) 1.52
Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young. Diabetologia (2007) 1.52
Psychosocial impacts of chlamydia testing are important. BMJ (2001) 1.52
Eosinophilic oesophagitis in patients presenting with dysphagia--a prospective analysis. Aliment Pharmacol Ther (2008) 1.49
A checklist for judging preference-based measures of health related quality of life: learning from psychometrics. Health Econ (1999) 1.49
Campylobacter jejuni/coli meningitis in a neonate. Br Med J (1980) 1.48
How complete is a transurethral resection of the prostate? Br J Urol (1996) 1.45
Analysis of homologous recombination in cultured mammalian cells. Cold Spring Harb Symp Quant Biol (1984) 1.43
Carriage of antibiotic-resistant pneumococci among Asian children: a multinational surveillance by the Asian Network for Surveillance of Resistant Pathogens (ANSORP). Clin Infect Dis (2001) 1.42
Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokine (1991) 1.40
Kawasaki syndrome. J Assoc Physicians India (1989) 1.39
Hearing impairments in middle age: the acceptability, benefit and cost of detection (ABCD). Br J Audiol (1992) 1.39
Predictors of multi-organ dysfunction in heatstroke. Emerg Med J (2005) 1.38
Efficient correction of mismatched bases in plasmid heteroduplexes injected into cultured mammalian cell nuclei. Mol Cell Biol (1985) 1.37
Generation of cytotoxic T lymphocytes in vitro. V. Response of normal and immune spleen cells to subcellular alloantigens. J Immunol (1975) 1.36
Tyrosine crystals in salivary gland tumours. J Clin Pathol (1981) 1.35
Associations between Mycoplasma genitalium, Chlamydia trachomatis and pelvic inflammatory disease. J Clin Pathol (2003) 1.33
Hearing threshold in patients with diabetes mellitus. J Laryngol Otol (1989) 1.33
Population-based exposure measurements in EPA region 5: a phase I field study in support of the National Human Exposure Assessment Survey. J Expo Anal Environ Epidemiol (1996) 1.33
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes. Diabetes Obes Metab (2007) 1.30
Localization of the mdx mutation within the mouse dystrophin gene. EMBO J (1988) 1.29
rHuEPO treatment improves brain and cognitive function of anemic dialysis patients. Kidney Int (1991) 1.27
Control of myogenic differentiation by fibroblast growth factor is mediated by position in the G1 phase of the cell cycle. J Cell Biol (1985) 1.27
Serotyping of Streptococcus pneumoniae by agglutination assays: a cost-effective technique for developing countries. Bull World Health Organ (1996) 1.22
Serotyping of Streptococcus pneumoniae by coagglutination with 12 pooled antisera. J Clin Microbiol (1999) 1.22
In vivo activation of the cystic fibrosis transmembrane conductance regulator mutant deltaF508 in murine nasal epithelium. Proc Natl Acad Sci U S A (1997) 1.19
Respiratory syncytial virus infection results in activation of multiple protein kinase C isoforms leading to activation of mitogen-activated protein kinase. J Immunol (2001) 1.18
Review: improving end-of-life care: a critical review of the gold standards framework in primary care. Palliat Med (2010) 1.17
Rare germinal unequal crossing-over leading to recombinant gene formation and gene duplication in Arabidopsis thaliana. Proc Natl Acad Sci U S A (1999) 1.17
Risk factors associated with pelvic inflammatory disease. Sex Transm Infect (2006) 1.16
Investigating whether adverse prenatal and perinatal events are associated with non-clinical psychotic symptoms at age 12 years in the ALSPAC birth cohort. Psychol Med (2009) 1.16
CD14-independent responses to LPS require a serum factor that is absent from neonates. J Immunol (1995) 1.15
Factors relating to readmission of term and near-term neonates in the first two weeks of life. Early Discharge Survey Group of the Health Professional Advisory Board of the Greater New York Chapter of the March of Dimes. J Perinat Med (1999) 1.15
Modified latex agglutination test for rapid detection of Streptococcus pneumoniae and haemophilus influenzae in cerebrospinal fluid and direct serotyping of Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis (1996) 1.14
An oligo-screening strategy to fill gaps found during shotgun sequencing projects. DNA Seq (1998) 1.14
A pragmatic cluster randomized controlled trial of an educational intervention for GPs in the assessment and management of depression. Psychol Med (2004) 1.13
Invasive pneumococcal disease in Kanti Children's Hospital, Nepal, as observed by the South Asian Pneumococcal Alliance network. Clin Infect Dis (2009) 1.12
The gatekeeper and the wizard revisited. BMJ (1992) 1.12
An exploration of knowledge and attitudes related to pre-pregnancy care in women with diabetes. Diabet Med (2010) 1.11
Evaluation of a training package in the assessment and management of depression in primary care. Med Educ (1998) 1.10
Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test. Fertil Steril (1990) 1.10
Under-reporting of infectious gastrointestinal illness in British Columbia, Canada: who is counted in provincial communicable disease statistics? Epidemiol Infect (2007) 1.10
Complementary medicine must be research led and evidence based. BMJ (2000) 1.10
Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance. Br J Radiol (2011) 1.09
Role of EP2 receptors and cAMP in prostaglandin E2 regulated expression of type I collagen alpha1, lysyl oxidase, and cyclooxygenase-1 genes in human embryo lung fibroblasts. J Cell Biochem (1998) 1.09
Evaluation of a DVD for women with diabetes: impact on knowledge and attitudes to preconception care. Diabet Med (2012) 1.09
Nasopharyngeal colonization of infants in southern India with Streptococcus pneumoniae. Epidemiol Infect (1999) 1.09
Individualised patient care as an adjunct to standard care for promoting adherence to ocular hypotensive therapy: an exploratory randomised controlled trial. Eye (Lond) (2011) 1.08
Microbial quality of domestic and imported brands of bottled water in Trinidad. Int J Food Microbiol (2003) 1.08
Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR results in cervical lesions. J Clin Pathol (1998) 1.07
Preliminary survey of educational support for patients prescribed ocular hypotensive therapy. Eye (Lond) (2010) 1.07
In vitro synthesis of human immunodeficiency virus-specific antibodies in peripheral blood lymphocytes of infants. Proc Natl Acad Sci U S A (1989) 1.06